New injection shows promise for obesity – early trial underway
NCT ID NCT06679959
First seen Jan 11, 2026 · Last updated May 19, 2026 · Updated 15 times
Summary
This early-stage trial tests an injectable drug called ASC30 for chronic weight management in people with obesity. About 115 participants will receive either the drug or a placebo to check safety, side effects, and how the body processes the drug. The study also measures weight changes over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC WEIGHT MANAGEMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ascletis clinical site
San Antonio, Texas, 78209, United States
Conditions
Explore the condition pages connected to this study.